Group II metabotropic glutamate receptor-mediated activation of G-proteins in rat hippocampal and striatal membranes

Neuroscience Letters

Volumn 539, Issue , 2013, Pages 22-26

  Odagaki, Yuji ^a   Kinoshita, Masakazu ^a   Toyoshima, Ryoichi ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Allosteric modulator; G protein; Guanosine 5' O (3 35S thio)triphosphate ( 35S GTP S) binding; Hippocampus; Metabotropic glutamate receptor type 2; Striatum

Indexed keywords

2 (2,3 DICARBOXYCYCLOPROPYL)GLYCINE; 2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; EGLUMETAD; GLUTAMIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; LIGAND; LY 487379; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR ANTAGONIST; MICROTUBULE ASSOCIATED PROTEIN 4; N METHYL DEXTRO ASPARTIC ACID; QUISQUALIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; BRAIN CORTEX; BRAIN REGION; CORPUS STRIATUM; HIPPOCAMPUS; IC 50; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT;

ALLOSTERIC REGULATION; ANIMALS; CEREBRAL CORTEX; CORPUS STRIATUM; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HIPPOCAMPUS; MALE; MEMBRANES; PYRIDINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; SULFONAMIDES;

EID: 84875245037     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.01.033     Document Type: Article

References (34)

1. 3H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes. British Journal of Pharmacology 1998, 123:497-504.
2. Conn P.J., Lindsley C.W., Jones C.K. Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia. Trends in Pharmacological Sciences 2008, 30:25-31.
3. Conway S.J., Miller J.C., Howson P.A., Clark B.P., Jane D.E. Synthesis of phenylglycine derivatives as potent and selective antagonists of group III metabotropic glutamate receptors. Bioorganic and Medicinal Chemistry Letters 2001, 11:777-780.
4. Cravatt B.F., Prospero-Garcia O., Siuzdak G., Gilula N.B., Henriksen S.J., Boger D.L., Lerner R.A. Chemical characterization of a family of brain lipids that induce sleep. Science 1995, 268:1506-1509.
5. Fedorova I., Hashimoto A., Fecik R.A., Hedrick M.P., Hanus L.O., Boger D.L., Rice K.C., Basile A.S. Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems. Journal of Pharmacology and Experimental Therapeutics 2001, 299:332-342.
6. Gu G., Lorrain D.S., Wei H., Cole R.L., Zhang X., Daggett L.P., Schaffhauser H.J., Bristow L.J., Lechner S.M. Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: Implication in emotional responses and central disinhibition. Brain Research 2008, 1197:47-62.
7. Huidobro-Toro J.P., Harris R.A. Brain lipids that induce sleep are novel modulators of 5-hydroxytryptamine receptors. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:8078-8082.
8. Ito I., Kohda A., Tanabe S., Hirose E., Hayashi M., Mitsunaga S., Sugiyama H. 3,5-Dihydroxyphenylglycine: a potent agonist of metabotropic glutamate receptors. Neuroreport 1992, 3:1013-1016.
9. Jane D.E., Pittaway K., Sunter D.C., Thomas N.K., Watkins J.C. New phenylglycine derivatives with potent and selective antagonist activity at presynaptic glutamate receptors in neonatal rat spinal cord. Neuropharmacology 1995, 34:851-856.
10. Jane D.E., Thomas N.K., Tse H-W., Watkins J.C. Potent antagonists at the l-AP4- and (1S,3S)-ACPD-sensitive presynaptic metabotropic glutamate receptors in the neonatal rat spinal cord. Neuropharmacology 1996, 35:1029-1035.
11. Johnson M.P., Baez M., Jagdmann G.E., Britton T.C., Large T.H., Callagaro D.O., Tizzano J.P., Monn J.A., Schoepp D.D. Discovery of allosteric potentiators for the metabotropic glutamate 2 receptors: synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phynyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine. Journal of Medicinal Chemistry 2003, 46:3189-3192.
12. Kemp M.C., Jane D.E., Tse H-W., Roberts P.J. Agonists of cyclic AMP-coupled metabotropic glutamate receptors in adult rat cortical slices. European Journal of Pharmacology 1996, 309:79-85.
13. Kingston A.E., Ornstein P.L., Wright R.A., Johnson B.G., Mayne N.G., Burnett J.P., Belagaje R., Wu S., Schoepp D.D. LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology 1998, 37:1-12.
14. Ma D., Tian H., Sun H., Kozikowski A.P., Pshenichkin S., Wroblewski J.T. Synthesis and biological activity of cyclic analogues of MPPG and MCPG as metabotropic glutamate receptor antagonists. Bioorganic and Medicinal Chemistry Letters 1997, 7:1195-1197.
15. Miller J.C., Howson P.A., Conway S.J., Williams R.V., Clark B.P., Jane D.E. Phenylglycine derivatives as antagonists of group III metabotropic glutamate receptors expressed on neonatal rat primary afferent terminals. British Journal of Pharmacology 2003, 139:1523-1531.
16. Moghaddam B. Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia. Psychopharmacology 2004, 174:39-44.
17. Moghaddam B., Adams B.W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 1998, 281:1349-1352.
18. Monn J.A., Valli M.J., Massey S.M., Wright R.A., Salhoff C.R., Johnson B.G., Howe T., Alt C.A., Rhodes G.A., Robey R.L., Griffey K.R., Tizzano J.P., Kallman M.J., Helton D.R., Schoepp D.D. Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): A potent selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. Journal of Medicinal Chemistry 1997, 40:528-537.
19. Monn J.A., Valli M.J., Massey S.M., Hansen M.M., Kress T.J., Wepsiec J.P., Harkness A.R., Grutsch J.L., Wright R.A., Johnson B.G., Andis S.L., Kingston A., Tomlinson R., Lewis R., Griffey K.R., Tizzano J.P., Schoepp D.D. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): Identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors. Journal of Medicinal Chemistry 1999, 42:1027-1040.
20. Moroni F., Lombardi G., Thomsen C., Leonardi P., Attucci S., Peruginelli F., Torregrossa S.A., Pellegrini-Giampietro D.E., Luneia R., Pellicciari R. Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist. Journal of Pharmacology and Experimental Therapeutics 1997, 281:721-729.
21. 35S]thio)triphosphate binding assay. Basic & Clinical Pharmacology & Toxicology 2011, 109:175-185.
22. Ohishi H., Shigemoto R., Nakanishi S., Mizuno N. Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat. Neuroscience 1993, 53:1009-1018.
23. Ohishi H., Neki A., Mizuno N. Distribution of a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat and mouse: An immunohistochemical study with a monoclonal antibody. Neuroscience Research 1998, 30:65-82.
24. Ornstein P.L., Bleisch T.J., Arnold M.B., Kennedy J.H., Wright R.A., Johnson B.G., Tizzano J.P., Helton D.R., Kallman M.J., Schoepp D.D. 2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability. Journal of Medicinal Chemistry 1998, 41:358-378.
25. Palucha A., Pilc A. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs. Pharmacology & Therapeutics 2007, 115:116-147.
26. Pellicciari R., Luneia R., Costantino G., Marinozzi M., Natalini B., Jakobsen P., Kanstrup A., Lombardi G., Moroni F., Thomsen C. 1-Aminoindan-1,5-dicarboxylic acid: a novel antagonist at phospholipase C-linked metabotropic glutamate receptors. Journal of Medicinal Chemistry 1995, 38:3717-3719.
27. 35S]GTPγS binding. Journal of Comparative Neurology 2005, 487:15-27.
28. Schaffhauser H., Rowe B.A., Morales S., Chavez-Noriega L.E., Yin R., Jachec C., Rao S.P., Bain G., Pinkerton A.B., Vernier J-M., Bristow L.J., Varney M.A., Daggett L.P. Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2. Molecular Pharmacology 2003, 64:798-810.
29. 3H]-LY354740 binding to rat mGlu2 and mGlu3 receptors expressed in CHO cells using Semliki Forest virus vectors. Neuropharmacology 2000, 39:1700-1706.
30. Sekiyama N., Hayashi Y., Nakanishi S., Jane D.E., Tse H-W., Brise E.F., Watkins J.C. Structure-activity relationships of new agonists and antagonists of different metabotropic glutamate receptor subtypes. British Journal of Pharmacology 1996, 117:1493-1503.
31. Thomas N.K., Jane D.E., Hse H-W., Watkins J.C. α-Methyl derivatives of serine-O-phosphate as novel, selective competitive metabotropic glutamate receptor antagonists. Neuropharmacology 1996, 35:637-642.
32. Vinson P.N., Conn P.J. Metabotropic glutamate receptors as therapeutic targets for schizophrenia. Neuropharmacology 2012, 62:1461-1472.
33. Wright R.A., Schoepp D.D. Differentiation of group 2 and 3 metabotropic glutamate receptor cAMP responses in the rat hippocampus. European Journal of Pharmacology 1996, 297:275-282.
34. 3H]LY459477 autoradiography. Neuropharmacology 2013, 66:89-98.